With the credit facility, SBi will fully repay $13 million of its existing debt and will build upon its core business by funding the introduction in 2010 of several new products and improved versions of existing products for both the upper and lower limb anatomies, according to the release.
SBi also plans to build-out instrument sets to further support its product portfolio and to focus on evidence-based medicine, by developing and initiating several studies to better support clinical understanding of its product portfolio, according to the release.
Read the release about Small Bone Innovations.
